Company Filing History:
1 out of 48 
1 out of 5 
1 out of 15 Years Active: 2019
Title: Daniela Kuehn: Innovator in Parvovirus Vaccine Development
Introduction
Daniela Kuehn is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. Her innovative work focuses on utilizing mutated parvovirus structural proteins for vaccine applications.
Latest Patents
Kuehn holds 1 patent for her invention titled "Mutated parvovirus structural proteins as vaccines." This patent describes a method for identifying a parvovirus mutated structural protein that can specifically bind to an antigen binder. The invention includes a parvovirus mutated structural protein that comprises at least one B-cell epitope heterologous to the parvovirus, a multimeric structure containing the protein, a nucleic acid encoding the protein, and methods for preparing the protein. Additionally, it covers the use of the protein in a medicament.
Career Highlights
Throughout her career, Daniela Kuehn has worked with notable organizations, including Medigene AG and Ludwig-Maximilians-Universität. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Kuehn has collaborated with esteemed colleagues such as Hildegard Buening and John Nieland. These partnerships have further enriched her research endeavors and have led to significant advancements in her field.
Conclusion
Daniela Kuehn is a trailblazer in the development of innovative vaccine technologies. Her work on parvovirus structural proteins showcases her commitment to advancing medical science and improving public health.